Copyright
©The Author(s) 2025.
World J Gastrointest Pharmacol Ther. Dec 5, 2025; 16(4): 110843
Published online Dec 5, 2025. doi: 10.4292/wjgpt.v16.i4.110843
Published online Dec 5, 2025. doi: 10.4292/wjgpt.v16.i4.110843
Table 1 Studies showing therapeutic role of enteric nervous system on functional bowel disorders
| No. | Ref. | Study characteristics | Key role of ENS |
| 1 | Baj et al[54] | Investigates the potential therapeutic use of marine toxins in treating visceral pain associated with gastrointestinal disorders | Focuses on the role of ENS in visceral pain perception and potential modulation via marine toxins |
| 2 | Bosi et al[55] | Examines how hyaluronan regulates neuronal and immune function in the rat small intestine and microbiota following ischemia/reperfusion injury | Highlights the ENS's involvement in gut motility and immune responses, particularly in the context of injury |
| 3 | Chai et al[56] | Studies the role of stem cell growth factor/c-Kit in the pathogenesis of IBS | Focuses on ENS's involvement in the pathophysiology of IBS, particularly in neuroimmune interactions |
| 4 | Chang et al[57] | Investigates how targeting enteric glial CRF-R1/Cx43 attenuates stress-induced accelerated colonic motility | Demonstrates the role of enteric glia and receptors in stress-induced gastrointestinal dysfunction |
| 5 | Chen et al[58] | Explores how patchouli alcohol restores gut homeostasis in IBS with diarrhea through neurotransmitter regulation via myosin Va | ENS plays a key role in restoring intestinal balance and regulating gut motility in IBS through neurotransmission |
| 6 | Cheng[59] | Identifies calcium-sensing receptor as a new therapeutic target for diarrhea | Focuses on how ENS receptors can be targeted to improve gastrointestinal disorders, specifically diarrhea |
| 7 | Del Colle et al[60] | Explores novel aspects of enteric serotonergic signaling in both health and brain-gut diseases | Examines serotonergic signaling in the ENS and its implications for gut function and diseases like IBS |
| 8 | Dong et al[61] | Investigates the role of Na+/Ca2+ exchanger 1 as a mechanosensitive molecule in esophageal myenteric neurons | Highlights the mechanosensitive role of ENS neurons in regulating esophageal motility and responsiveness |
| 9 | Guarino et al[62] | Explores the role of the gastrointestinal neuromuscular apparatus as an underestimated target of gut microbiota | Focuses on the interaction between ENS, microbiota, and neuromuscular function in gastrointestinal health |
| 10 | Gulbransen and Christofi[63] | Investigates the potential of targeting enteric glia in gastrointestinal diseases and motility disorders | Highlights the emerging therapeutic role of enteric glia in modulating motility disorders and disease states |
| 11 | Holland et al[64] | Discusses the regulation of microRNA in enteric nervous system development and its role in disease | Emphasizes the role of microRNAs in ENS development, function, and the onset of gastrointestinal diseases |
| 12 | Holzer and Holzer-Petsche[65] | Studies how anti-calcitonin gene-related peptide migraine therapeutics may cause constipation by antagonizing the motor functions of the intestine | Examines the ENS's involvement in gastrointestinal motility affected by treatments for other conditions |
| 13 | Kimono[66] | Discusses gastrointestinal issues and therapeutic approaches in Gulf War illness | Focuses on the complex interplay between the ENS and the broader neurological and immune systems in disease contexts |
| 14 | Linan-Rico et al[67] | Investigates the role of enteric glial cells in inflammation and their potential therapeutic implications for GI diseases | Highlights the critical role of ENS glial cells in inflammation and their therapeutic potential in gastrointestinal disorders |
| 15 | Mace et al[68] | Provides insights into the pharmacology and physiology of gastrointestinal enteroendocrine cells | Explores the interaction between ENS and enteroendocrine cells in regulating gut physiology and responses |
| 16 | Morales-Soto and Gulbransen[69] | Discusses how enteric glia significantly contributes to abdominal pain in gastrointestinal discomfort | Sheds light on the role of ENS glial cells in mediating abdominal pain and their emerging role in therapeutic strategies |
| 17 | O'Mahony et al[70] | Examines the connection between early-life stress and the development of irritable bowel syndrome and psychiatric comorbidities | Investigates the role of the ENS in the brain-gut axis, highlighting its importance in IBS and related conditions |
| 18 | Tait and Sayuk[71] | Studies the brain-gut-microbiota axis in functional gastrointestinal illnesses and potential therapeutic interventions | Explores the role of the ENS as a mediator between the brain, gut, and microbiota in functional gastrointestinal disorders |
| 19 | Weber[72] | Discusses new treatment options for irritable bowel syndrome with predominant diarrhea | Focuses on therapeutic targets within the ENS to treat IBS with diarrhea |
| 20 | Zhang et al[73] | Explores how EphrinB2/ephB2 activation facilitates colonic synaptic potentiation and contributes to long-term visceral hypersensitivity in IBS | Focuses on the role of synaptic plasticity in the ENS, contributing to visceral hypersensitivity in IBS |
Table 2 Studies showing therapeutic role of enteric nervous system on inflammatory bowel disease
| No. | Ref. | Study characteristics | Key role of ENS |
| 1 | Belarif et al[91] | Investigates the influence of the IL-7 receptor on anti-TNF responsiveness and T-cell gut homing in IBD | Focuses on how the IL-7 receptor affects the ENS by influencing T-cell migration and responsiveness to anti-TNF therapy |
| 2 | Boldyreva et al[92] | Highlights the gut-brain axis and non-obvious factors involved in IBD | Explores the communication between the ENS and brain, and how it impacts the development and progression of IBD |
| 3 | Bosáková et al[93] | Studies the role of serotonin in attenuating TNF-induced intestinal inflammation through interaction with human mucosal tissue | Investigates serotonin's effects on the ENS and its potential to modulate inflammation in the gut via interaction with mucosal tissue |
| 4 | Hawker et al[94] | Explores the role of Mas-related G protein-coupled receptors in gastrointestinal dysfunction and IBD | Examines the involvement of Mas-related receptors in ENS-mediated gastrointestinal functions, particularly in IBD |
| 5 | Lê et al[95] | Reviews therapeutic strategies for IBD involving modulation of the microbiota and the introduction of pre-, pro-, syn-, or postbiotics | Focuses on how microbiota manipulation impacts ENS function, providing new therapeutic strategies for IBD management |
| 6 | Ochoa-Cortes et al[96] | Discusses enteric glial cells as a new frontier in neurogastroenterology and a potential clinical target for IBD | Highlights the growing importance of enteric glial cells in IBD, providing potential new targets for clinical treatment |
| 7 | Robinson et al[97] | Investigates the neuroprotective effects of bone marrow mesenchymal stem cells in TNBS-induced colitis | Demonstrates how stem cells interact with the ENS to protect against damage and restore function in gastrointestinal disorders |
| 8 | Sahakian et al[98] | Identifies molecular targets to alleviate enteric neuropathy and gastrointestinal dysfunction | Focuses on targeting specific molecules in the ENS to relieve neuropathy and restore normal gastrointestinal function |
| 9 | Stavely et al[99] | Explores strategies for targeting enteric neurons and plexitis as a way to manage IBD | Emphasizes the role of enteric neurons and the plexuses in managing inflammation and dysfunction in IBD |
Table 3 Studies showing therapeutic role of enteric nervous system on gastrointestinal motility disorders
| No. | Ref. | Study characteristics | Key role of ENS |
| 1 | Bessard et al[112] | Investigates alterations in prostanoid expression and intestinal epithelial barrier functions that contribute to ileus | Highlights how disruptions in ENS signaling and epithelial function lead to impaired motility and ileus development |
| 2 | Bonaz[113] | Discusses the role of enteric neuropathy and the vagus nerve in gastrointestinal disorders, with therapeutic implications | Explores how enteric neuropathy and vagal signaling impact gut function, offering insights into treatment strategies |
| 3 | Brun et al[114] | Studies how Toll-like receptor-2 regulates glial-derived neurotrophic factor production in intestinal smooth muscle cells | Focuses on how glial cells in the ENS influence smooth muscle function and gut motility via neurotrophic factor production |
| 4 | Ferreira-Duarte et al[115] | Explores the interaction between the renin-angiotensin system and enteric neurotransmission in colonic dysmotility in TNBS-induced colitis | Highlights the interplay between systemic signaling and the ENS, leading to dysmotility in inflammatory conditions like colitis |
| 5 | Filpa et al[116] | Investigates the role of glutamatergic neurotransmission in the ENS and its role in the brain-gut axis in health and disease | Explores how glutamate signaling in the ENS influences gut-brain communication and impacts gastrointestinal disorders |
| 6 | Floettmann et al[117] | Provides the pharmacological profile of Naloxegol, a peripherally acting μ-opioid receptor antagonist for opioid-induced constipation | Focuses on the interaction between opioid receptors in the ENS and peripheral opioid antagonism to treat constipation |
| 7 | Gao et al[118] | Investigates μ-opioid receptor-mediated enteric glial activation in morphine-induced constipation | Highlights the activation of enteric glia through opioid receptors, contributing to constipation in opioid use |
| 8 | Sanger et al[119] | Discusses the role of ghrelin and motilin control systems in gastrointestinal physiology and therapeutics | Explores the control of gastrointestinal motility via ghrelin and motilin systems, which interact with the ENS for motility regulation |
| 9 | Stakenborg et al[120] | Reviews pathophysiology and current therapeutic approaches to postoperative ileus | Discusses how the ENS is involved in the pathophysiology of ileus and how therapies targeting ENS dysfunction can improve recovery |
- Citation: Agrawal H, Agarwal N, Gupta N. Enteric nervous system as a therapeutic target in gastrointestinal disorders. World J Gastrointest Pharmacol Ther 2025; 16(4): 110843
- URL: https://www.wjgnet.com/2150-5349/full/v16/i4/110843.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v16.i4.110843
